President Trump readying drug pricing executive orders
Roche Tecentriq-Avastin combo fails to hit primary endpoint in ovarian cancer trial
Moderna's COVID vaccine could see $5B or more in sales, say analysts
Biopharma M&A show quantity if not quality
*please scroll down for all the latest news*